thymidine has been researched along with Ovarian Neoplasms in 86 studies
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These human adenocarcinoma cells do not significantly change FDG uptake with chronic hyperglycemia while acute hyperglycemia markedly reduces uptake of FDG and thymidine." | 7.69 | Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine. ( Clavo, AC; Torizuka, T; Wahl, RL, 1997) |
| "Fifty-six tumor specimens from patients with ovarian adenocarcinoma were tested for sensitivity to single and combination drug regimens in a short-term antimetabolic assay measuring inhibition of thymidine incorporation." | 7.68 | Combination chemotherapy tested in a short-term thymidine incorporation assay in primary cultures of ovarian adenocarcinomas. ( Hayward, IP; Hurst, T; Khoo, SK; Parsons, PG, 1992) |
| "Uptake of tritiated thymidine, L-leucine, L-methionine and FDG into two human tumor cell lines (HTB 63 melanoma and HTB 77 IP3 ovarian carcinoma) was determined after a 4-hr exposure to each of three different oxygen atmospheres (0, 1." | 3.69 | Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells. ( Clavo, AC; Wahl, RL, 1996) |
| "These human adenocarcinoma cells do not significantly change FDG uptake with chronic hyperglycemia while acute hyperglycemia markedly reduces uptake of FDG and thymidine." | 3.69 | Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine. ( Clavo, AC; Torizuka, T; Wahl, RL, 1997) |
| "Antiproliferation effects of PROG on 3AO and AO ovarian carcinoma cells were determined by 3H-thymidine incorporation." | 3.69 | Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. ( Bu, SZ; Gao, QR; Jiang, LZ; Pei, G; Ren, XH; Wu, ZJ; Yin, DL, 1997) |
| "Fifty-six tumor specimens from patients with ovarian adenocarcinoma were tested for sensitivity to single and combination drug regimens in a short-term antimetabolic assay measuring inhibition of thymidine incorporation." | 3.68 | Combination chemotherapy tested in a short-term thymidine incorporation assay in primary cultures of ovarian adenocarcinomas. ( Hayward, IP; Hurst, T; Khoo, SK; Parsons, PG, 1992) |
| "The growth inhibitory effects, the reduction of [3H]-TdR incorporation and the perturbation of the cell cycle induced by the new agent mitozolomide on the M14 human melanoma cell line and on the SW626 human ovarian cancer cell line were compared to those produced by BCNU." | 3.67 | Mitozolomide activity on human cancer cells in vitro. ( D'Incalci, M; Erba, E; Landoni, F; Lorico, A; Mangioni, C; Morasca, L; Pepe, S; Ubezio, P, 1986) |
| "Cyclin D1 is a cell cycle regulator of G1 progression that has been suggested to play a relevant role in the pathogenesis of several human cancer types." | 1.30 | Expression of cyclin D1 correlates with malignancy in human ovarian tumours. ( Alama, A; Barbieri, F; Cagnoli, M; Foglia, G; Pedullà, F; Ragni, N, 1997) |
| "Data on ovarian cancer patients relapse-free survival (RFS) were abstracted from the Lankenau Hospital Tumor Registry and RFS was plotted using the Kaplan-Meier method." | 1.30 | The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. ( Caradonna, S; Dabrow, MB; Francesco, MR; McBrearty, FX, 1998) |
| "Regulation of ovarian cancer growth is poorly understood." | 1.28 | Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1. ( Leung, BS; Zhou, L, 1992) |
| "We used an ovarian cancer cell line (OC-3L-VGH) to compare the accuracy of the MTT and the [3H]-TdR incorporation assay in measuring chemosensitivity of 7 anticancer drugs." | 1.28 | Chemosensitivity testing of an ovarian cancer cell line: comparison of MTT assay and [3H]-thymidine incorporation. ( Chang, CC; Chao, KC; Kan, YY; Ng, HT; Yu, KJ, 1991) |
| "We have compared the ability of cancer tissue to proliferate in native-state culture to the stage and histological grade of four major types of human carcinomas: breast, ovarian, colon, and lung." | 1.28 | Cancer biology for individualized therapy: correlation of growth fraction index in native-state histoculture with tumor grade and stage. ( Bordin, GM; Connors, KM; Hoffman, RM; Robb, JA; Umbreit, JN; Vescio, RA; Youngkin, T, 1990) |
| "Tumor sensitivity of ovarian cancer to cytotoxic drugs in vitro was examined between paired samples taken from the primary tumor and its metastases in the same patient." | 1.28 | In vitro sensitivity of ovarian cancer as determined by a short-term biochemical assay: comparison between primary and metastatic sites in the same patient. ( Hurst, T; Khoo, SK; Lark, J; Mackay, EV; Parsons, P; Webb, MJ, 1989) |
| "A human ovarian cancer cell line, A2780, derived from an untreated ovarian cancer patient and relatively sensitive to cisplatin was treated by stepwise incubation with cisplatin to produce a cisplatin-resistant variant, 2780CP." | 1.27 | Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. ( Fojo, A; Hamilton, TC; Lai, GM; Masuda, H; Ozols, RF; Rothenberg, M, 1988) |
| "1." | 1.26 | An approach to the problem of heterogeneity of human tumour-cell populations. ( Sirachý, J, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 47 (54.65) | 18.7374 |
| 1990's | 27 (31.40) | 18.2507 |
| 2000's | 11 (12.79) | 29.6817 |
| 2010's | 1 (1.16) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, SH | 1 |
| Choi, SJ | 1 |
| Oh, JH | 1 |
| Chae, SW | 1 |
| Nam, K | 1 |
| Park, JS | 1 |
| Lee, HJ | 1 |
| Sauer, G | 1 |
| Kafka, A | 1 |
| Grundmann, R | 1 |
| Kreienberg, R | 1 |
| Zeillinger, R | 1 |
| Deissler, H | 1 |
| Conover, CA | 1 |
| Khosla, S | 1 |
| Yagyu, T | 1 |
| Kobayashi, H | 1 |
| Wakahara, K | 1 |
| Matsuzaki, H | 1 |
| Kondo, T | 1 |
| Kurita, N | 1 |
| Sekino, H | 1 |
| Inagaki, K | 1 |
| Suzuki, M | 1 |
| Kanayama, N | 1 |
| Terao, T | 1 |
| Parasassi, T | 1 |
| Brunelli, R | 1 |
| Bracci-Laudiero, L | 1 |
| Greco, G | 1 |
| Gustafsson, AC | 1 |
| Krasnowska, EK | 1 |
| Lundeberg, J | 1 |
| Lundeberg, T | 1 |
| Pittaluga, E | 1 |
| Romano, MC | 1 |
| Serafino, A | 1 |
| Hoffman, J | 1 |
| Post, J | 1 |
| Teufel, G | 2 |
| D'Incalci, M | 3 |
| Erba, E | 3 |
| Balconi, G | 1 |
| Morasca, L | 2 |
| Garattini, S | 1 |
| Behling, H | 2 |
| Altrock, H | 1 |
| Krafft, W | 2 |
| Schirmer, A | 1 |
| Preibsch, W | 1 |
| Brückmann, D | 1 |
| Starke, ID | 1 |
| Woodcock, TM | 1 |
| Martin, DS | 1 |
| Damin, LA | 1 |
| Kemeny, NE | 1 |
| Young, CW | 1 |
| Alama, A | 5 |
| Chiara, S | 2 |
| Merlo, F | 2 |
| Ragni, N | 4 |
| Conte, PF | 3 |
| Meazza, R | 2 |
| Reggiardo, G | 1 |
| Ferrari, I | 1 |
| Rosso, R | 1 |
| Yano, T | 1 |
| Pinski, J | 1 |
| Radulovic, S | 1 |
| Schally, AV | 1 |
| Sen, S | 1 |
| Sessa, C | 1 |
| Vikhanskaya, FL | 1 |
| Higashi, K | 2 |
| Clavo, AC | 4 |
| Wahl, RL | 4 |
| Barbieri, F | 2 |
| Biassoni, R | 1 |
| Mazzei, M | 1 |
| Nicolin, A | 2 |
| Ektova, LV | 1 |
| Iartseva, IV | 1 |
| Khorosheva, EV | 1 |
| Ivanova, TP | 1 |
| Iavorskaia, NP | 1 |
| Mel'nik, SIa | 1 |
| Torizuka, T | 1 |
| Biade, S | 1 |
| Stobbe, CC | 1 |
| Chapman, JD | 1 |
| Bu, SZ | 1 |
| Yin, DL | 1 |
| Ren, XH | 1 |
| Jiang, LZ | 1 |
| Wu, ZJ | 1 |
| Gao, QR | 1 |
| Pei, G | 1 |
| Cagnoli, M | 1 |
| Pedullà, F | 1 |
| Foglia, G | 1 |
| Falcioni, R | 1 |
| Antonini, A | 1 |
| Nisticò, P | 1 |
| Di Stefano, S | 1 |
| Crescenzi, M | 1 |
| Natali, PG | 1 |
| Sacchi, A | 1 |
| Silvestrini, R | 2 |
| Daidone, MG | 2 |
| Veneroni, S | 1 |
| Benini, E | 1 |
| Scarfone, G | 1 |
| Zanaboni, F | 1 |
| Villa, A | 1 |
| Presti, M | 1 |
| Danese, S | 1 |
| Bolis, G | 1 |
| Dabrow, MB | 1 |
| Francesco, MR | 1 |
| McBrearty, FX | 1 |
| Caradonna, S | 1 |
| Bagnato, A | 1 |
| Tecce, R | 1 |
| Moretti, C | 1 |
| Di Castro, V | 1 |
| Spergel, D | 1 |
| Catt, KJ | 1 |
| Rahman, NA | 1 |
| Huhtaniemi, I | 1 |
| Savarese, TM | 1 |
| Mitchell, K | 1 |
| McQuain, C | 1 |
| Campbell, CL | 1 |
| Guardiani, R | 1 |
| Wuu, J | 1 |
| Ollari, C | 1 |
| Reale, F | 1 |
| Nelson, BE | 1 |
| Chen, A | 1 |
| Quesenberry, PJ | 1 |
| Ivarsson, K | 1 |
| Sundfeldt, K | 1 |
| Brännström, M | 1 |
| Hellberg, P | 1 |
| Janson, PO | 1 |
| Ohtani, K | 1 |
| Sakamoto, H | 1 |
| Kikuchi, A | 1 |
| Nakayama, Y | 1 |
| Idei, T | 1 |
| Igarashi, N | 1 |
| Matukawa, T | 1 |
| Satoh, K | 1 |
| Meyer, JS | 1 |
| Gersell, DJ | 1 |
| Yim, S | 1 |
| Colic, M | 1 |
| Vucevic, D | 1 |
| Jandric, D | 1 |
| Medic-Mijacevic, L | 1 |
| Rakic, L | 1 |
| Salihoglu, Y | 1 |
| Bilir, A | 1 |
| Aydiner, A | 1 |
| Erkan, M | 1 |
| Tuzlali, S | 1 |
| Eralp, Y | 1 |
| Rho, YS | 1 |
| Kim, SA | 1 |
| Jung, JC | 1 |
| Shin, CC | 1 |
| Chang, SG | 1 |
| Pfleiderer, A | 1 |
| Doerjer, O | 1 |
| Weigand, J | 1 |
| Mathews, CK | 1 |
| Ueda, K | 1 |
| Toyokawa, M | 1 |
| Nakamori, H | 1 |
| Sako, H | 1 |
| Umesaki, N | 1 |
| Nakade, J | 1 |
| Lee, T | 1 |
| Sugawa, T | 1 |
| Kondrat'eva, NA | 3 |
| Dobrynin, IaV | 3 |
| Merkulov, MF | 3 |
| Sirachý, J | 1 |
| Volm, M | 1 |
| Kaufmann, M | 1 |
| Wayss, K | 1 |
| Mattern, J | 1 |
| Boente, MP | 1 |
| Berchuck, A | 2 |
| Rodriguez, GC | 2 |
| Davidoff, A | 1 |
| Whitaker, R | 1 |
| Xu, FJ | 1 |
| Marks, J | 1 |
| Clarke-Pearson, DL | 2 |
| Bast, RC | 2 |
| Zhou, L | 1 |
| Leung, BS | 1 |
| Hayward, IP | 1 |
| Hurst, T | 4 |
| Parsons, PG | 1 |
| Khoo, SK | 4 |
| Muttini, MP | 1 |
| Guido, T | 1 |
| Nicolò, G | 1 |
| Yu, KJ | 1 |
| Ng, HT | 1 |
| Chao, KC | 1 |
| Chang, CC | 1 |
| Kan, YY | 1 |
| Whitaker, RS | 1 |
| Schlossman, D | 1 |
| Weber, G | 1 |
| Nagai, M | 1 |
| Prajda, N | 1 |
| Nakamura, H | 1 |
| Szekeres, T | 1 |
| Olah, E | 1 |
| Vescio, RA | 1 |
| Connors, KM | 1 |
| Youngkin, T | 1 |
| Bordin, GM | 1 |
| Robb, JA | 1 |
| Umbreit, JN | 1 |
| Hoffman, RM | 1 |
| Chan, TC | 1 |
| Howell, SB | 1 |
| Daunter, B | 1 |
| Cham, BE | 1 |
| Sariban, E | 1 |
| Sitaras, NM | 1 |
| Antoniades, HN | 1 |
| Kufe, DW | 1 |
| Pantazis, P | 1 |
| Rodgers, KE | 1 |
| Montz, FJ | 1 |
| Scott, L | 1 |
| Condon, S | 1 |
| Fujimori, K | 1 |
| diZerega, GS | 1 |
| Lark, J | 1 |
| Webb, MJ | 3 |
| Parsons, P | 1 |
| Mackay, EV | 2 |
| Masuda, H | 1 |
| Ozols, RF | 1 |
| Lai, GM | 1 |
| Fojo, A | 1 |
| Rothenberg, M | 1 |
| Hamilton, TC | 1 |
| Wagner, F | 1 |
| Tsushima, K | 1 |
| Podratz, KC | 1 |
| Stanhope, CR | 1 |
| Lieber, MM | 1 |
| Pepe, S | 1 |
| Ubezio, P | 1 |
| Lorico, A | 1 |
| Mangioni, C | 1 |
| Landoni, F | 1 |
| Di Marco, E | 1 |
| Favoni, RE | 1 |
| Hanson, JA | 1 |
| Bean, EA | 1 |
| Coombs, AM | 1 |
| Moore, JL | 1 |
| Zaffaroni, N | 1 |
| Sanfilippo, O | 1 |
| Gasparini, G | 1 |
| Uematsu, K | 1 |
| Huggins, C | 1 |
| Hauri, HP | 1 |
| Brachetti, A | 1 |
| Leonhardt, A | 1 |
| Limburg, H | 1 |
| Osswald, H | 1 |
| Schmähl, D | 1 |
| Robinson, E | 1 |
| Sher, S | 1 |
| Mekori, T | 1 |
| Strubel, HB | 1 |
| Rindt, W | 1 |
| Hoffmann, G | 1 |
| Schirazi, M | 1 |
| Oertel, GW | 1 |
| Sato, G | 2 |
| Clark, J | 1 |
| Posner, M | 1 |
| Leffert, H | 1 |
| Paul, D | 1 |
| Morgan, M | 1 |
| Colby, C | 1 |
| Jagarlamoody, SM | 1 |
| Aust, JC | 1 |
| Tew, RH | 1 |
| McKhann, CF | 1 |
| Jones, KL | 1 |
| Gospodarowicz, D | 1 |
| Iversen, OH | 1 |
| Iversen, U | 1 |
| Ziegler, JL | 1 |
| Bluming, AZ | 1 |
| Mavligit, GM | 1 |
| Ambus, U | 1 |
| Gutterman, JU | 1 |
| Hersh, EM | 1 |
| McBride, CM | 1 |
| Nikolaev, AIa | 1 |
| Kozlov, EA | 1 |
| Sokolov, NN | 1 |
| Merkulov, M | 1 |
| Leskova, S | 1 |
| Timofeevskaia, EA | 2 |
| Tolkacheva, EN | 1 |
| Kozinets, GI | 1 |
| Bogoiavlenskaia, MP | 1 |
| Al'perovich, VV | 1 |
| Bykova, IA | 1 |
| Orlov, GP | 1 |
| Sheehy, PF | 1 |
| Wakonig-Vaartaja, T | 1 |
| Winn, R | 1 |
| Clarkson, BD | 1 |
| Turbina, IL | 1 |
| Mezentseva, SK | 1 |
| Karuzina, NP | 1 |
| Leskova, SG | 1 |
| Wolberg, WH | 1 |
| De Cecco, L | 1 |
| Rugiati, S | 1 |
| Sorbi, RT | 1 |
| Clarkson, B | 1 |
| Ota, K | 1 |
| Ohkita, T | 1 |
| O'Connor, A | 1 |
2 trials available for thymidine and Ovarian Neoplasms
| Article | Year |
|---|---|
Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; DNA, Neopl | 1994 |
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy | 1998 |
84 other studies available for thymidine and Ovarian Neoplasms
| Article | Year |
|---|---|
Nonviral gene delivery to human ovarian cancer cells using arginine-grafted PAMAM dendrimer.
Topics: Arginine; Cell Proliferation; Dendrimers; DNA, Antisense; ErbB Receptors; Female; Gene Transfer Tech | 2011 |
Basal expression of the multidrug resistance gene 1 (MDR-1) is associated with the TT genotype at the polymorphic site C3435T in mammary and ovarian carcinoma cell lines.
Topics: Adenocarcinoma; beta 2-Microglobulin; Breast Neoplasms; DNA Primers; Drug Resistance, Multiple; Drug | 2002 |
Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts.
Topics: Animals; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cattle; Cell Division; Cells, Cultured; Collag | 2003 |
A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
Topics: Cell Division; Cell Line, Tumor; Cysteine Proteinase Inhibitors; DNA, Complementary; Female; Humans; | 2004 |
Differentiation of normal and cancer cells induced by sulfhydryl reduction: biochemical and molecular mechanisms.
Topics: Acetylcysteine; beta Catenin; Cadherins; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiatio | 2005 |
In vivo studies of DNA synthesis in human normal and tumor cells.
Topics: Aged; Digestive System; DNA; DNA, Neoplasm; Female; Gastrointestinal Neoplasms; Humans; Injections, | 1967 |
[Experiences with Volm's short-term tumor test in the primary treatment of ovarian carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cell Division; Cells, Cultured; Cisplatin | 1984 |
Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites.
Topics: Altretamine; Cell Line; Cells; Female; Humans; Ovarian Neoplasms; Thymidine; Time Factors; Triazines | 1980 |
[In vitro autoradiography - method for biological characterisation of ovarian carcinomas, with reference to clinical requirements (author's transl)].
Topics: Adenocarcinoma; Antineoplastic Agents; Autoradiography; Cells, Cultured; Female; Humans; Ovarian Neo | 1982 |
Granulocyte content and tritiated thymidine uptake of mononuclear cell preparations from patients with ovarian cancer.
Topics: Adult; Aged; Carboxylic Ester Hydrolases; Female; Granulocytes; Humans; Leukocyte Count; Lymphocyte | 1982 |
Combination clinical trials with thymidine and fluorouracil: a phase I and clinical pharmacologic evaluation.
Topics: Adult; Aged; Bone Marrow; Colonic Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Flu | 1980 |
Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.
Topics: Cell Division; Cystadenocarcinoma, Papillary; Estradiol; Female; Gonadotropin-Releasing Hormone; Hum | 1994 |
Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid.
Topics: Antineoplastic Agents; Cell Cycle; DNA, Neoplasm; Drug Screening Assays, Antitumor; Female; Folic Ac | 1994 |
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
Topics: Adenocarcinoma; Cell Division; Deoxyglucose; DNA, Neoplasm; Female; Flow Cytometry; Fluorodeoxygluco | 1993 |
In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.
Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Methionin | 1993 |
Antiproliferative effect of DNA polymerase alpha antisense oligodeoxynucleotides on breast cancer cells.
Topics: Adenocarcinoma; Base Sequence; Breast Neoplasms; Cell Division; DNA Polymerase II; DNA Replication; | 1993 |
[Synthesis and biological properties of pyrimidine 2'-deoxynucleosides modified by a residue of quinaldic acid].
Topics: Animals; Antineoplastic Agents; Cell Division; Chickens; Deoxyuridine; DNA; Female; Humans; Nucleic | 1995 |
Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells.
Topics: Cell Hypoxia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Leucine; Me | 1996 |
Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine.
Topics: Adenocarcinoma; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperg | 1997 |
The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles.
Topics: Cell Cycle; Cell Division; Cell Survival; Cesium Radioisotopes; Colonic Neoplasms; DNA, Neoplasm; Do | 1997 |
Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Blotting, Northern; Carcinoma; Cell Cycle; Cell Division | 1997 |
Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blotting, Western; Carcinoma; Cell Division; Cell Transf | 1997 |
Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.
Topics: 3T3 Cells; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; Breast Neoplasms; | 1997 |
The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Topics: Cell Division; Cells, Cultured; Disease-Free Survival; Dose-Response Relationship, Drug; Epithelial | 1998 |
Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells.
Topics: Calcium; Cell Division; Endothelin-1; Female; Humans; Neoplasm Proteins; Ovarian Neoplasms; Receptor | 1995 |
Hormonal regulation of proliferation of granulosa and Leydig cell lines derived from gonadal tumors of transgenic mice expressing the inhibin-alpha subunit promoter/simian virus 40 T-antigen fusion gene.
Topics: Activins; Animals; Antigens, Polyomavirus Transforming; Artificial Gene Fusion; DNA, Neoplasm; Femal | 1999 |
Coexpression of granulocyte colony stimulating factor and its receptor in primary ovarian carcinomas.
Topics: Cell Survival; Epidermal Growth Factor; Female; Granulocyte Colony-Stimulating Factor; Humans; Immun | 2001 |
Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells.
Topics: Adult; Aged; Aged, 80 and over; Cell Count; Cell Division; Colorimetry; Epithelial Cells; Female; Fo | 2001 |
Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system.
Topics: Cell Division; Cell Line; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Female; Follicle S | 2001 |
Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Middle Aged; Mixed | 2001 |
8-Chloro-cAMP modulates apoptosis of thymocytes and thymocyte hybridoma.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antibodies, Monoclonal; Apoptosis; CD4 Antigens; CD | 2001 |
Thymidine labeling index in epithelial ovarian cancer.
Topics: Adult; Aged; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Radionucli | 2001 |
Anticancer cytotoxicity and nephrotoxicity of the new platinum (II) complexes containing diaminocyclohexane and glycolic acid.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Coloring Agents; Cyclohexanes; DNA; Female; Glucose | 2002 |
[Investigations about the incorporation of nucleotide precursors in single cell suspensions of ovarian- and cervix-carcinomas under the influence of cytostatic therapy (author's transl)].
Topics: Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Ovarian Neoplasms; Thymidine; Tritium; Uri | 1977 |
Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Culture M | 1975 |
Immunosuppressive effect of serum in patients with ovarian carcinoma.
Topics: Adult; Aged; Blood; Female; Humans; Immunity, Cellular; Immunosuppression Therapy; Middle Aged; Ovar | 1978 |
[Biological properties of L-asparaginase preparations from E. coli in cell cultures].
Topics: Asparaginase; Burkitt Lymphoma; Cell Line; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Stabili | 1978 |
An approach to the problem of heterogeneity of human tumour-cell populations.
Topics: Antineoplastic Agents; Cell Nucleus; Chromosomes, Human; Female; Humans; Mitosis; Neoplasm Metastasi | 1979 |
[Cellular test system for studying the biological properties of preparations with L-asparaginase activity].
Topics: Animals; Antineoplastic Agents; Asparaginase; Biological Assay; Burkitt Lymphoma; Cells, Cultured; C | 1977 |
[Testing of the resistance of human tumours in the short-term test (author's transl)].
Topics: Antibiotics, Antineoplastic; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Female; Human | 1975 |
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.
Topics: Antibodies, Monoclonal; Cells, Cultured; Epithelium; ErbB Receptors; Female; Humans; Interferon-gamm | 1992 |
Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1.
Topics: Cell Division; DNA Replication; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Ovarian Neo | 1992 |
Combination chemotherapy tested in a short-term thymidine incorporation assay in primary cultures of ovarian adenocarcinomas.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Cyclophosph | 1992 |
Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma.
Topics: Carcinoma; Cell Division; Drug Resistance; Female; Humans; Ovarian Neoplasms; Predictive Value of Te | 1992 |
Chemosensitivity testing of an ovarian cancer cell line: comparison of MTT assay and [3H]-thymidine incorporation.
Topics: Drug Screening Assays, Antitumor; Female; Humans; Ovarian Neoplasms; Tetrazolium Salts; Thymidine; T | 1991 |
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor.
Topics: Cells, Cultured; Epidermal Growth Factor; Epithelium; ErbB Receptors; Female; Humans; Ovarian Neopla | 1991 |
AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells.
Topics: Animals; Binding, Competitive; Cell Line; Dose-Response Relationship, Drug; Drug Synergism; Female; | 1991 |
Cancer biology for individualized therapy: correlation of growth fraction index in native-state histoculture with tumor grade and stage.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Division; Colonic Neoplasms; DNA Replication; Female; Humans; L | 1990 |
Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cyclic AMP; Dipyridamole; Drug Synergism; | 1990 |
Solasodine glycosides. In vitro preferential cytotoxicity for human cancer cells.
Topics: Carbohydrate Sequence; Carbohydrates; Cell Survival; Dose-Response Relationship, Drug; Female; Fibro | 1990 |
Expression of platelet-derived growth factor (PDGF)-related transcripts and synthesis of biologically active PDGF-like proteins by human malignant epithelial cell lines.
Topics: Binding, Competitive; Breast Neoplasms; Carcinoma; Cell Line; Colonic Neoplasms; Epithelium; Female; | 1988 |
Inhibition of ovarian cancer cell proliferation in vivo and incorporation of 3H-thymidine in vitro after follicle regulatory protein administration.
Topics: Adenocarcinoma; Adult; Animals; Drug Screening Assays, Antitumor; Female; Granulosa Cell Tumor; Grow | 1989 |
In vitro sensitivity of ovarian cancer as determined by a short-term biochemical assay: comparison between primary and metastatic sites in the same patient.
Topics: Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; Neoplasm Metastasis; Ovarian Neoplasms; | 1989 |
Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.
Topics: Aphidicolin; Bromodeoxyuridine; Cell Line; Cisplatin; Diterpenes; DNA Repair; Drug Resistance; Femal | 1988 |
Short-term in vitro chemosensitivity testing of tumours of the ovary, cervix and uterus. Measurement of DNA metabolism by 3H thymidine incorporation.
Topics: Antineoplastic Agents; Colony-Forming Units Assay; DNA; Dose-Response Relationship, Drug; Female; Ge | 1986 |
[Scintillation counting as an in vitro method for assessing the pretherapeutic effectiveness of planned tumor chemotherapy in patients with ovarian cancer].
Topics: Antineoplastic Agents; Cell Division; Cell Survival; Colony-Forming Units Assay; Female; Humans; Ova | 1987 |
In vitro chemotherapy sensitivity testing of human ovarian carcinoma: comparison of optical colony counting and [3H]thymidine incorporation assays.
Topics: Antineoplastic Agents; Carcinoma; Drug Screening Assays, Antitumor; Female; Humans; Middle Aged; Ova | 1987 |
Mitozolomide activity on human cancer cells in vitro.
Topics: Aged; Antineoplastic Agents; Carmustine; Cell Cycle; Cell Line; Dose-Response Relationship, Drug; Fe | 1986 |
Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cell Division; DNA Polymerase II; Female; Head and | 1986 |
Chemosensitivity testing of ovarian cancer: results of a rapid in vitro biochemical assay.
Topics: Adenocarcinoma; Carcinoma; Cells, Cultured; Cisplatin; Cystadenocarcinoma; DNA, Neoplasm; Endometrio | 1985 |
A comparison of two in vitro assays of cell response following in vitro drug and radiation exposures of human tumour xenograft cells.
Topics: Animals; Cell Line; Cell Survival; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Dose-Re | 1985 |
In vitro activity of alkylating agents on human tumors as measured by a short-term antimetabolic assay.
Topics: Alkylating Agents; Breast Neoplasms; Cells, Cultured; DNA, Neoplasm; Drug Evaluation, Preclinical; E | 1985 |
Induction of leukemia and ovarian tumors in mice by pulse-doses of polycyclic aromatic hydrocarbons.
Topics: Adrenal Glands; Animals; Benz(a)Anthracenes; Benzopyrenes; DNA; Female; Granulosa Cell Tumor; Leukem | 1968 |
[An invasive neoplasm from embryonic cells of Drosophila melanogaster cultured permanently in vivo (author's transl)].
Topics: Adipose Tissue; Animals; Chromosomes; Drosophila melanogaster; Female; Inclusion Bodies, Viral; Inte | 1974 |
[Clinical experiences with a combination therapy of metastasising genital and mammary carcinomas (author's transl)].
Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Cyclophosphamide; Cytidine; Drug Therapy, Combination; Fem | 1974 |
Lymphocyte stimulation by phytohemagglutinin and tumor cells of malignant effusions.
Topics: Antigens, Neoplasm; Ascitic Fluid; Breast Neoplasms; Cells, Cultured; Colonic Neoplasms; Female; Hum | 1974 |
Cytostatic effects of G-6-PDH inhibitors in cell cultures from normal and neoplastic tissue.
Topics: Breast Neoplasms; Cells, Cultured; Dehydroepiandrosterone; DNA; Female; Glucosephosphate Dehydrogena | 1974 |
Enrichment culture techniques for selection of cell culture strains with desirable physiological and genetic properties.
Topics: Animals; Bromodeoxyuridine; Carbon Isotopes; Culture Techniques; Female; Growth Hormone; Haploidy; H | 1971 |
In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
Topics: Adenocarcinoma; Animals; Antigen-Antibody Reactions; Antigens; Antigens, Neoplasm; Autoradiography; | 1971 |
Biological activity of a growth factor for ovarian cells.
Topics: Animals; Bucladesine; Cattle; Cell Count; Cell Division; Cell Line; Chromatography; Cyclic GMP; DNA; | 1974 |
The establishment of hormone-dependent cell lines.
Topics: Animals; Cell Line; Chromatography, Affinity; Culture Techniques; DNA; Female; Gonadotropins; Hormon | 1974 |
Cell kinetics in Burkitt lymphoma.
Topics: Adolescent; Ascitic Fluid; Burkitt Lymphoma; Child; Child, Preschool; Colchicine; Culture Techniques | 1974 |
Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
Topics: Antigens, Neoplasm; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Hodgkin Disease; Humans; | 1973 |
[Physicochemical properties and antileukemic activity of crystalline L-asparaginase from Escherichia coli].
Topics: Antineoplastic Agents; Asparaginase; Burkitt Lymphoma; Cell Line; Cells, Cultured; Chemical Phenomen | 1974 |
Incubation of surviving sections of ovarian tumours as a method of testing their sensitivity to cytostatics.
Topics: Culture Techniques; DNA, Neoplasm; Female; Fluorouracil; Humans; Melphalan; Nitrogen Mustard Compoun | 1972 |
[Use of the method of autoradiography to study the effect of thiophosphamide on human tumor cell cultures].
Topics: Autoradiography; Carcinoma; Cell Line; DNA, Neoplasm; Female; Humans; Mesenchymoma; Methods; Mitosis | 1972 |
[Change in peripheral blood lymphocytes with radiotherapy].
Topics: Adult; Breast Neoplasms; Choriocarcinoma; Female; Humans; Lectins; Leukocytes; Lymphocyte Activation | 1972 |
Asynchronous DNA synthesis and asynchronous mitosis in multinuclear ovarian cancer cells.
Topics: Aneuploidy; Ascitic Fluid; Autoradiography; Cell Nucleus; Chlorambucil; Cystadenocarcinoma; Cystaden | 1974 |
[On hematopoietic changesin patients with malignant ovarian tumors during chemotherapy].
Topics: Antineoplastic Agents; Cyclophosphamide; Female; Hematopoiesis; Humans; Ovarian Neoplasms; Thiotepa; | 1965 |
[The effect of thio-TEPA on the incorporation of labeled precursors into DNA and protein of human neoplastic cells in tissue culture].
Topics: Carbon Isotopes; Culture Techniques; DNA, Neoplasm; Female; Humans; Neoplasm Proteins; Ovarian Neopl | 1968 |
[Effect of thiophosphamide and 5-fluorouracil on the incorporation of H 3-thymidine into DNA of surviving ovarian cancer sections].
Topics: Culture Techniques; Depression, Chemical; DNA, Neoplasm; Female; Fluorouracil; Humans; Ovarian Neopl | 1971 |
Response of DNA thymine synthesis in human tumor and normal tissue to 5-fluorouracil.
Topics: Breast Neoplasms; Carbon Isotopes; Chromatography, Paper; Colon; Colonic Neoplasms; Depression, Chem | 1972 |
[Analysis of the cellular kinetics of ovarian adenocarcinomatous tissue].
Topics: Adenocarcinoma; Autoradiography; Carcinoma; DNA; Endometrium; Female; Humans; In Vitro Techniques; M | 1970 |
Kinetics of proliferation of cancer cells in neoplastic effusions in man.
Topics: Adenocarcinoma; Antineoplastic Agents; Autoradiography; Cell Division; DNA, Neoplasm; Exudates and T | 1965 |